Acurx Pharmaceuticals, Inc.
NASDAQ: ACXP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David Luci
- Employees
- 4
- Headquarters
- Staten Island, United States
- IPO year
- 2021
- Market cap
- $2.3M
- Website
- https://www.acurxpharma.com
Loading ACXP…
Loading profile data…Frequently asked questions about ACXP
What does Acurx Pharmaceuticals, Inc. (ACXP) do?
Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate is ibezapolstat, an antibiotic that utilizes a novel mechanism of action by targeting the polymerase IIIC enzyme. Ibezapolstat has successfully comp...
Where does ACXP trade?
Acurx Pharmaceuticals, Inc. (ACXP) trades on the NASDAQ Capital Market.
What sector is ACXP in?
Acurx Pharmaceuticals, Inc. (ACXP) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Acurx Pharmaceuticals, Inc.?
David Luci is the chief executive officer of Acurx Pharmaceuticals, Inc. (ACXP).
Where is Acurx Pharmaceuticals, Inc. headquartered?
Acurx Pharmaceuticals, Inc. is headquartered in United States.
Does ACXP pay a dividend?
Acurx Pharmaceuticals, Inc. (ACXP) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ACXP go public?
Acurx Pharmaceuticals, Inc. (ACXP) completed its initial public offering in 2021.